Center Reproductive Medicine is categorized under Clinics in Beaumont, TX and active since 2007.
Center Reproductive Medicine was established in 2007, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Clinics business, which does work in the B2C market, and is classified as a Clinics, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Marilyn Bean, Manager at the company’s single location by writing to 3350 Dowlen Road # East, Beaumont, Texas TX 77706 or by phoning (409) 898-1603. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Center Reproductive Medicine |
| Contact Person: | Marilyn Bean, Manager |
| Address: | 3350 Dowlen Road # East, Beaumont, Texas 77706 |
| Phone Number: | (409) 898-1603 |
| Website Address: | infertilitytexas.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Clinics |
| SIC Code: | 8011 |
| NAICS Code: | 6214930 |
| Share This Business: |
Center Reproductive Medicine was started in 2007 to provide professional Clinics under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Marilyn Bean, Manager for inquiries that concern Center Reproductive Medicine by calling the company number (409) 898-1603, as your correspondence is most welcome. Additionally, the physical location of the single location of Center Reproductive Medicine can be found at the coordinates 30.11009,-94.16843 as well as the street address 3350 Dowlen Road # East in Beaumont, Texas 77706.
For its online presence, you may visit Center Reproductive Medicine’s website at infertilitytexas.com and engage with its social media outlets through on Twitter and on Facebook.